Second Tokushima Factory, Otsuka Pharmaceutical Co recalls
Second Tokushima Factory, Otsuka Pharmaceutical Co has 4 recalls on record with the FDA and USDA, the earliest in 2024 and the latest reported on 1 May 2024. 4 are still ongoing. The most frequent reason is packaging defects.
Total recalls4since 2024
Last 12 months0reported
Class I00% of total
Ongoing4latest 1 May 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 4 100%
Why second tokushima factory, otsuka pharmaceutical co is recalled
By year
Ongoing second tokushima factory, otsuka pharmaceutical co recalls
4 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify | Second Tokushima Factory, Otsuka Pharmaceutical Co | Packaging Defects | Nationwide |
| Drug | CLASS III | Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify | Second Tokushima Factory, Otsuka Pharmaceutical Co | Packaging Defects | Nationwide |
| Drug | CLASS III | Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify | Second Tokushima Factory, Otsuka Pharmaceutical Co | Packaging Defects | Nationwide |
| Drug | CLASS III | Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify | Second Tokushima Factory, Otsuka Pharmaceutical Co | Packaging Defects | Nationwide |
All second tokushima factory, otsuka pharmaceutical co recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify | Second Tokushima Factory, Otsuka Pharmaceutical Co | Packaging Defects | Nationwide |
| Drug | CLASS III | Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify | Second Tokushima Factory, Otsuka Pharmaceutical Co | Packaging Defects | Nationwide |
| Drug | CLASS III | Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify | Second Tokushima Factory, Otsuka Pharmaceutical Co | Packaging Defects | Nationwide |
| Drug | CLASS III | Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify | Second Tokushima Factory, Otsuka Pharmaceutical Co | Packaging Defects | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.